−0.020CAD
−1.84 MCAD
153.49 KCAD
31.65 M
About BIOMARK DIAGNOSTICS INC.
Sector
Industry
CEO
Rashid Ahmed Maula Bux
Website
Headquarters
Richmond
Founded
2014
ISIN
CA09073K1084
FIGI
BBG0086KMY57
BioMark Diagnostics, Inc. engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company was founded by Rashid Ahmed Bux on June 19, 2014 and is headquartered in Richmond, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BUX is 0.25 CAD — it has increased by 28.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange BIOMARK DIAGNOSTICS INC. stocks are traded under the ticker BUX.
Yes, you can track BIOMARK DIAGNOSTICS INC. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BUX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARK DIAGNOSTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARK DIAGNOSTICS INC. EBITDA is −1.46 M CAD, and current EBITDA margin is −1.01 K%. See more stats in BIOMARK DIAGNOSTICS INC. financial statements.